# Coherus Biosciences Inc. (CHRS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$181M |
| 2024 | -$200M |
| 2023 | -$203M |
| 2022 | -$257M |
| 2021 | -$264M |
| 2020 | $156M |
| 2019 | $108M |
| 2018 | -$204M |
| 2017 | -$232M |
| 2016 | -$116M |
| 2015 | -$219M |
| 2014 | -$65M |
| 2013 | -$36M |
| 2012 | -$39M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$36M |
| 2025-09-30 | -$44M |
| 2025-06-30 | -$45M |
| 2025-03-31 | -$45M |
| 2024-09-30 | -$47M |
| 2024-06-30 | -$40M |
| 2024-03-31 | -$68M |
| 2023-09-30 | -$32M |
| 2023-06-30 | -$35M |
| 2023-03-31 | -$68M |
| 2022-09-30 | -$80M |
| 2022-06-30 | -$44M |
| 2022-03-31 | -$81M |
| 2021-09-30 | -$33M |
| 2021-06-30 | -$24M |
| 2021-03-31 | -$167M |
| 2020-09-30 | $34M |
| 2020-06-30 | $65M |
| 2020-03-31 | $41M |
| 2019-09-30 | $52M |
| 2019-06-30 | $27M |
| 2019-03-31 | -$17M |
| 2018-09-30 | -$57M |
| 2018-06-30 | -$45M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CHRS/operating-income)